Upsala J Med Sci 95: 299-300, 1990 List op Planned Associated Projects in the NORDKEM Project 5/89 on Medical Need for Quality Specifications in Laboratory Medicine - No. 1. 2. 3. 4. 5. 6. 7 . 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. ParticiDants Title Hqrder M,Olivarius N, Jqrgensen PJ, Diabetes in Primary Bihlet I, Hyltoft Petersen P Fraser C, Hyltoft Petersen P Antonsen S Grodum E, Hyltoft Petersen P, Hangaard J, Bollerslev J et al. Djurhus S, Rohold A, Vadstrup S, Hyltoft Petersen P Magid E, Hyltoft Petersen P et al. Heedman P-A, Olsson S, Larsson 0 Ritter B, Marsell R, Ostergaard H, Olander B, Akerblom A Arends J, Hyltoft Petersen P, Nqrgaard-Pedersen B Uldall A, Blaabjerg 0 Tryding N et al. Nilsson Ehle P Westgard J 0, Hyltoft Petersen P Sandberg S Kaikola H-L Penttila I M Lindstedt G Lindstedt G Lytken-Larsen M, Fraser C, Hyltoft Petersen P Health Care Quality Specifications for Detection Limit Reference interval for cortisol at CRH-test Reference intervals for S--Potassium Evaluation of clinical tests Prevalence of idiop. hemochromatosis and hypercholest. 18 y men Qual. spec. maternal S-a-Fetoproteinanalys Planning & implement. of Nordic reference S Analyt. specificity, tests in primary care Qual. spec. S--Cholest S--Cholest.Clin strat, anal. qual.,control system Qual. spec. for tests in primary care - 1 8 - Qual. spec. S--a-Feto- protein Qual . spec. thyroid hormones Qual. spec. prostate specific antigen Qual. spec. - HbA,, 299 18. Xofstad J, Momsen G, Gade Christensen N 19. Nilsson Ehle H 20. Linnet C 21. Linnet C 22. Dybkaer R , Hyltoft Petersen P, de Verdier C-H et al. 23. Stenman U-H 24. Brandslund I, Borg Rasmussen J 25. Sorto A, Kaihola H-L Qual. spec. B--pH,pCO,, PO2 I Ca" Qual. spec. iron de- ficiency parame- ters Anal. goals for P-- Bilirubin (unconj) determinations Anal. goals for P-- Creatinine determ. Nomenclature Qual. spec. for human choriogonado- tropin (hCG) Conc a,-antitrypsin in workers in dusty work areas Quality goals & orga- nization of QC in pri- mary care lab. In the associated projects the quality specification work should be performed for each analytical quantity in each specified situation. Models for estimation of needed quality and for specification of acceptable analytical performance and critical errors have been developed during the past ten years. These models should be applied to the clinical strategy in the project, whether a screening, a diagnostic situation or a time-related pathological process. Each clinical situation should be analyzed concerning the type of model to be used, and - if no relevant model is available - to develop or elaborate new and useful models. The main project group must be directly involved by providing the associated groups with the available literature and, if needed, to help the groups to find their relevant models or to try to develop new useful models. On the other hand the main project group should try to compile the collected knowledge and make it useful. 300